Northern Capital Management (Wisconsin)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Northern Capital Management (Wisconsin)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$3.42M	Buy	47,625 +1,485	+3%	+$120K	0.92%	38
2018 Q3	$4.42M	Sell	46,140 -995	-2%	-$96.5K	1.02%	36
2018 Q2	$4.49M	Sell	47,135 -1,195	-2%	-$110K	1.09%	30
2018 Q1	$4.24M	Sell	48,330 -1,230	-2%	-$112K	1.09%	29
2017 Q4	$4.21M	Buy	49,560 +2,275	+5%	+$191K	1.08%	24
2017 Q3	$4.09M	Sell	47,285 -1,105	-2%	-$88.6K	1.26%	21
2017 Q2	$3.73M	Buy	48,390 +1,095	+2%	+$77.7K	1.39%	18
2017 Q1	$3.28M	Buy	47,295 +2,155	+5%	+$145K	1.31%	23
2016 Q4	$2.67M	Buy	45,140 +875	+2%	+$54K	1.12%	33
2016 Q3	$2.93M	Sell	44,265 -115	-0.3%	-$7.11K	1.32%	24
2016 Q2	$2.4M	Buy	44,380 +3,880	+10%	+$213K	1.07%	36
2016 Q1	$2.09M	Buy	40,500 +37,275	+1,156%	+$1.94M	0.93%	43
2015 Q4	$226K	Hold	3,225	–	–	0.1%	138
2015 Q3	$201K	Hold	3,225	–	–	0.09%	142
2015 Q2	$271K	Sell	3,225 -90	-3%	-$7K	0.13%	122
2015 Q1	$249K	Hold	3,315	–	–	0.12%	123
2014 Q4	$206K	Buy	+3,315	New	+$189K	0.1%	136
2013 Q3	–	Sell	-6,510	Closed	-$226K	–	144
2013 Q2	$226K	Buy	+6,510	New	+$229K	0.14%	109

Other funds holding XBI

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

Northern Capital Management (Wisconsin)'s XBI Position: Q4 2018 in Review

Northern Capital Management (Wisconsin) increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.2% in Q4 2018, buying an estimated $120K and bringing the position to 47,625 shares worth $3.42M. The position accounts for 0.92% of the portfolio, ranked #38.

Northern Capital Management (Wisconsin) first reported a position in XBI in Q2 2013 and has held it in 18 quarters since. The position peaked at $4.49M in Q2 2018. 427 funds tracked by Wall St. Rank hold XBI as of Q4 2018.

Northern Capital Management (Wisconsin) held 47,625 shares of State Street SPDR S&P Biotech ETF worth $3.42M as of Q4 2018.
Northern Capital Management (Wisconsin) bought 1,485 State Street SPDR S&P Biotech ETF shares in Q4 2018, an estimated $120K.
State Street SPDR S&P Biotech ETF made up 0.92% of Northern Capital Management (Wisconsin)'s portfolio in Q4 2018, its #38 holding.
Northern Capital Management (Wisconsin) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 18 quarters since.
Northern Capital Management (Wisconsin)'s State Street SPDR S&P Biotech ETF position peaked at $4.49M in Q2 2018.
427 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2018.

Based on Northern Capital Management (Wisconsin)'s 13F filing for Q4 2018, filed 1 Feb 2019.